Published in Trends Microbiol on September 01, 2000
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta (2007) 3.24
Antibiotics as signalling molecules. Philos Trans R Soc Lond B Biol Sci (2007) 2.74
Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A (2007) 2.34
ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res (2004) 1.88
Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest (2005) 1.64
The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J Bacteriol (2004) 1.63
Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog (2010) 1.60
Salmonella DNA adenine methylase mutants confer cross-protective immunity. Infect Immun (2001) 1.59
The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58
Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother (2001) 1.56
From antimicrobial to anticancer peptides. A review. Front Microbiol (2013) 1.56
Analysis and prediction of antibacterial peptides. BMC Bioinformatics (2007) 1.54
Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun (2010) 1.48
Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol (2013) 1.42
Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology (2002) 1.41
Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide. Front Microbiol (2011) 1.39
Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics (2009) 1.39
Innate immune defences in the human endometrium. Reprod Biol Endocrinol (2003) 1.35
Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights. Solid State Nucl Magn Reson (2009) 1.33
Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta (2008) 1.31
De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol (2008) 1.30
Secondary structure and lipid contact of a peptide antibiotic in phospholipid bilayers by REDOR. Biophys J (2004) 1.27
Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol (2009) 1.27
The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect Immun (2011) 1.25
Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol (2004) 1.25
Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother (2007) 1.24
Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem J (2004) 1.22
Salmonellae PhoPQ regulation of the outer membrane to resist innate immunity. Curr Opin Microbiol (2014) 1.16
Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob Agents Chemother (2009) 1.16
AntiBP2: improved version of antibacterial peptide prediction. BMC Bioinformatics (2010) 1.15
Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR. Biochim Biophys Acta (2009) 1.12
ATP release from human airway epithelial cells studied using a capillary cell culture system. J Physiol (2002) 1.12
Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol (2002) 1.10
Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB. J Bacteriol (2010) 1.09
Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med (2008) 1.09
Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect Immun (2010) 1.08
Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother (2004) 1.08
Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide. Biochem J (2005) 1.06
NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J Biol Chem (2009) 1.05
The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G. Infect Immun (2003) 1.05
Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Pediatr Surg Int (2005) 1.04
Mechanisms of alpha-defensin bactericidal action: comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue. Biochemistry (2008) 1.04
In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria. Antimicrob Agents Chemother (2004) 1.04
Orientation determination of protein helical secondary structures using linear and nonlinear vibrational spectroscopy. J Phys Chem B (2009) 1.04
Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol (2010) 1.03
Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid-state NMR. Biophys J (2004) 1.03
pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Proc Natl Acad Sci U S A (2014) 1.03
Bacterial sensing of antimicrobial peptides. Contrib Microbiol (2009) 1.03
Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep (2012) 1.02
Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am J Respir Cell Mol Biol (2005) 1.02
The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects. J Bacteriol (2009) 1.02
Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother (2005) 1.00
Antibacterial mechanism of action of arylamide foldamers. Antimicrob Agents Chemother (2011) 0.99
Reduced gene expression of intestinal alpha-defensins predicts diarrhea in a cohort of African adults. J Infect Dis (2006) 0.99
The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury. J Transl Med (2011) 0.99
Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence (2011) 0.99
The potential of antimicrobial peptides as biocides. Int J Mol Sci (2011) 0.99
Peptide design for antimicrobial and immunomodulatory applications. Biopolymers (2013) 0.99
Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides. Antimicrob Agents Chemother (2003) 0.99
Antimicrobial protegrin-1 forms ion channels: molecular dynamic simulation, atomic force microscopy, and electrical conductance studies. Biophys J (2010) 0.98
Quinolones sensitize gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother (2006) 0.97
Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97
Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity. Infect Immun (2007) 0.97
Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss. Infect Immun (2005) 0.97
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob Agents Chemother (2008) 0.96
Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes. Biophys J (2005) 0.96
Active internalization of the Penicillium chrysogenum antifungal protein PAF in sensitive aspergilli. Antimicrob Agents Chemother (2003) 0.96
Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob Agents Chemother (2004) 0.95
Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16. Antimicrob Agents Chemother (2014) 0.95
Snake Venom: Any Clue for Antibiotics and CAM? Evid Based Complement Alternat Med (2005) 0.95
Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95
Synergy of histone-derived peptides of coho salmon with lysozyme and flounder pleurocidin. Antimicrob Agents Chemother (2001) 0.95
Membrane orientation of MSI-78 measured by sum frequency generation vibrational spectroscopy. Langmuir (2011) 0.94
Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother (2006) 0.94
Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother (2008) 0.94
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial. PLoS One (2015) 0.93
Neutrophil-Mediated Phagocytosis of Staphylococcus aureus. Front Immunol (2014) 0.93
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother (2009) 0.93
Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin. Antimicrob Agents Chemother (2012) 0.91
The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics. J Bacteriol (2013) 0.91
De-novo design of antimicrobial peptides for plant protection. PLoS One (2013) 0.91
Peptide-induced domain formation in supported lipid bilayers: direct evidence by combined atomic force and polarized total internal reflection fluorescence microscopy. Biophys J (2010) 0.91
Crystal structure and functional mechanism of a human antimicrobial membrane channel. Proc Natl Acad Sci U S A (2013) 0.91
Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. PLoS One (2014) 0.90
Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria. Appl Environ Microbiol (2003) 0.90
Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis. Immunology (2013) 0.89
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B. Antimicrob Agents Chemother (2008) 0.89
Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J (2005) 0.89
Structure-function relationship studies on the frog skin antimicrobial peptide tigerinin 1: design of analogs with improved activity and their action on clinical bacterial isolates. Antimicrob Agents Chemother (2002) 0.89
Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis. Antimicrob Agents Chemother (2005) 0.89
The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect Immun (2006) 0.89
Analysis and prediction of highly effective antiviral peptides based on random forests. PLoS One (2013) 0.89
Characterization of a regulatory network of peptide antibiotic detoxification modules in Lactobacillus casei BL23. Appl Environ Microbiol (2013) 0.88
The Vibrio cholerae VprA-VprB two-component system controls virulence through endotoxin modification. MBio (2014) 0.88
Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region. PLoS One (2013) 0.87
Changes in salivary antimicrobial peptides, immunoglobulin A and cortisol after prolonged strenuous exercise. Eur J Appl Physiol (2011) 0.87
Solid-state 19F-NMR analysis of 19F-labeled tryptophan in gramicidin A in oriented membranes. Biophys J (2002) 0.87
Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation. PLoS Negl Trop Dis (2013) 0.87
Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med (1970) 7.27
A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. J Biol Chem (1988) 2.33
Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J (1972) 2.25
Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect Immun (1996) 2.20
Filling pressures in the right and left sides of the heart in acute myocardial infarction. A reappraisal of central-venous-pressure monitoring. N Engl J Med (1971) 2.00
Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol (2000) 1.92
CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem (2000) 1.89
Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J Biol Chem (1997) 1.77
Diastolic pressure-volume relationship in the canine left ventricle. Circ Res (1971) 1.74
Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol (1996) 1.67
Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man. Circulation (1972) 1.60
Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child (1988) 1.54
Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect Immun (1998) 1.48
Mapping of DNAase I sensitive regions on mitotic chromosomes. Cell (1984) 1.45
Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med (1976) 1.45
Antimicrobial peptides in the airway. Curr Top Microbiol Immunol (2006) 1.32
Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med (1976) 1.28
Expression of mammalian defensin genes. J Leukoc Biol (2000) 1.21
Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity. Antimicrob Agents Chemother (2000) 1.19
The genetic analysis of mammalian cell-cycle mutants. Annu Rev Genet (1985) 1.12
Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model. Circulation (1972) 1.09
Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun (2001) 1.08
Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract. J Nutr (1998) 1.02
Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer (1986) 1.01
Early increase in left ventricular compliance after myocardial infarction. J Clin Invest (1972) 0.98
Expression of beta-defensin genes in bovine alveolar macrophages. Infect Immun (1998) 0.93
Cloning and expression of bovine neutrophil beta-defensins. Biosynthetic profile during neutrophilic maturation and localization of mature peptide to novel cytoplasmic dense granules. J Biol Chem (1999) 0.92
Mean electromechanical P- t: an indirect index of the peak rate of rise of left ventricular pressure. Am J Cardiol (1972) 0.92
High-resolution FISH mapping of beta-defensin genes to river buffalo and sheep chromosomes suggests a chromosome discrepancy in ffttle standard karyotypes. Cytogenet Cell Genet (1996) 0.91
Silent mitral insufficiency in acute myocardial infarction. Circulation (1971) 0.90
Clinical evaluation of left ventricular pressures in myocardial infarction. Circulation (1972) 0.88
Cryotherapy for active retinopathy of prematurity. Ophthalmology (1986) 0.85
Somatic cell mapping of beta-defensin genes to cattle syntenic group U25 and fluorescence in situ localization to chromosome 27. Mamm Genome (1995) 0.85
Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans. Mol Oral Microbiol (2010) 0.84
Production of active bovine tracheal antimicrobial peptide in milk of transgenic mice. Proc Natl Acad Sci U S A (1996) 0.84
Induction of a rat enteric defensin gene by hemorrhagic shock. Infect Immun (1999) 0.84
Energy expenditure and genotype of children with cystic fibrosis. Pediatr Res (1994) 0.84
Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity. Mol Oral Microbiol (2010) 0.83
The Developmental and Family Services Unit--a model AIDS project serving developmentally disabled children and their families. AIDS Care (1989) 0.82
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol (1992) 0.82
Soft-tissue sarcomas of the head and neck in children. Int J Radiat Oncol Biol Phys (1983) 0.82
Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. J Perinatol (2011) 0.81
Ocular findings in cystic fibrosis. Am J Ophthalmol (1987) 0.81
Differential regulation of innate immune response genes in gingival epithelial cells stimulated with Aggregatibacter actinomycetemcomitans. J Periodontal Res (2007) 0.81
Pulmonary artery catheterization. A new technique in treatment of acute myocardial infarction. Geriatrics (1971) 0.80
Molecular biological strategies in the analysis of antibiotic peptide gene families. The use oligonucleotides as hybridization probes. Methods Mol Biol (1997) 0.78
High-dose corticosteroids as adjunct therapy in severe Pneumocystis carinii pneumonia. AIDS Res (1986) 0.78
Catheterization of left ventricle in acutely ill patients. Br Heart J (1971) 0.78
Clinical applications of exercise nuclear cardiology studies in the era of healthcare reform. Am J Cardiol (1995) 0.78
Maple syrup urine disease (MSUD): screening for known mutations in Italian patients. J Inherit Metab Dis (1994) 0.78
Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man. Br Heart J (1971) 0.77
Early detection of coronary artery disease. Adv Cardiol (1979) 0.77
Analysis of regional ischemic left ventricular dysfunction by quantitative cineangiography. Circulation (1979) 0.76
Rapid separation of p-nitrophenol and its glucuronide and sulfate conjugates by reversed-phase high-performance liquid chromatography. J Chromatogr (1979) 0.76
Dissociation between indices of pump performance and contractility in patients with coronary artery disease and acute myocardial infarction. Chest (1975) 0.76
In vivo beta-defensin gene expression in rat gingival epithelium in response to Actinobacillus actinomycetemcomitans infection. J Periodontal Res (2006) 0.76
Comparison of hemodynamic, electrocardiographic, mechanical, and metabolic indicators of intraoperative myocardial ischemia in vascular surgical patients with coronary artery disease. Anesthesiology (1989) 0.76
Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography. N Engl J Med (1982) 0.76
Cloning of a human S-phase cell cycle gene: use of transient expression for screening. Mol Cell Biol (1987) 0.75
Anaesthesia for abdominal vascular surgery in patients with coronary artery disease (CAD), Part I: Isoflurane produces dose-dependent coronary vasodilation. Acta Anaesthesiol Scand (1994) 0.75
Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon. Am J Cardiol (1971) 0.75
Family therapy. Aust Fam Physician (1986) 0.75
An improbable criterion of normality. Circulation (1982) 0.75
Ophthalmic considerations in cranio-orbital surgery. Clin Plast Surg (1987) 0.75
Increase in threshold to ventricular activation related to atrial contraction: a possible example of Wedensky inhibition". Am Heart J (1971) 0.75
Cryotherapy for active retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol (1987) 0.75
Contextual therapy: brief treatment of an addict and spouse. Fam Process (1990) 0.75
[Cardiokymography: noninvasive assessment of the regional myocardial wall motion in the detection of coronary artery disease (author's transl)]. Z Kardiol (1978) 0.75
Dose-response relations in the nephrotoxic action of mercury based on "spot urine" samples. Acta Pharmacol Toxicol (Copenh) (1986) 0.75
Anaesthesia for abdominal aortic surgery in patients with coronary artery disease, Part II: Effects of nitrous oxide on systemic and coronary haemodynamics, regional ventricular function and incidence of myocardial ischaemia. Acta Anaesthesiol Scand (1994) 0.75
Cardiokymography: a new method for assessing segmental wall motion in man. Adv Cardiol (1978) 0.75